Interleukin-6 Blocking Therapy for COVID-19: From Immune Pathogenesis to Clinical Outcomes

As a newly emerged infectious disease, the coronavirus disease 2019 (COVID-19) has caused millions of deaths, resulting in a global health challenge. Currently, several vaccines have been approved with significant benefits against disease transmission. However, effective therapies are still needed f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Fan, Wu, Ling, Zhu, Xiaoxia, Zhang, Lijun, Liu, Dongzhou, Wu, Lijun, Zou, Hejian, Lu, Liwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242140/
https://www.ncbi.nlm.nih.gov/pubmed/35772080
http://dx.doi.org/10.2478/rir-2022-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242140/
https://www.ncbi.nlm.nih.gov/pubmed/35772080
http://dx.doi.org/10.2478/rir-2022-0002

Ejemplares similares